Journal of Inorganic Materials, Volume. 38, Issue 1, 3(2023)

Nanomaterials and Biosensing Technology for the SARS-CoV-2 Detection

Yanyan LI1...2, Yusi PENG1,2, Chenglong LIN1,2, Xiaoying LUO3, Zheng TENG4,*, Xi ZHANG4, Zhengren HUANG1,2, and Yong YANG12,* |Show fewer author(s)
Author Affiliations
  • 11. State Key Laboratory of High Performance Ceramics and Superfine Microstructures, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai 200050, China
  • 22. College of Materials Science and Opto-Electronics Engineering, University of Chinese Academy of Sciences, Beijing 100049, China
  • 33. State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200032, China
  • 44. Shanghai Provincial Center for Disease Control and Prevention, Shanghai 200336, China
  • show less
    Figures & Tables(20)
    TEM image (A) and schemetic morphology (B) of SARS-CoV-2[9]
    Classification (a, c), symptoms (b) and structure (c) of coronavirus[16]
    Scheme of the lab-on-a-chip genosensor for SARS- CoV-2 virus detection[35]
    Principle workflow of ddPCR in analyzing clinical samples[37]
    Detection of SARS-CoV-2 based on CRISPR-Cas12 combined with lateral flow technique[44]
    Change of human immune response after viral infection[16]
    ELISA method for detection of SARS-CoV-2[16]
    Schematic illustration of the SERS-based immunoassay[77]
    Schematic diagram of operation procedure of COVID-19 SERS sensor[8]
    Application of SnS2 microspheres for diagnosing the infectiousness of SARS-CoV-2[80]
    Schematic diagram of nano-plasma optic sensor for detection of SARS-CoV-2[89]
    SARS-CoV-2 detection based on 5G-enabled fluorescence biosensor[100]
    Magnetic beads-based electrochemical assay for SARS-CoV-2 detection in untreated saliva[126]
    Principle of the proposed electrochemical biosensor for sensitive analysis of SARS-CoV-2 RNA[136]
    Schematic diagram of rapid direct identification of SARS-CoV-2 using PMO-functionalized G-FET nano-sensors[148]
    Schematic diagram of detection of SARS-CoV-2 RNA based on magnetic particle spectroscopy biosensors[166]
    Detection process of SARS-CoV-2 of the magnetic relaxation switches assay with ULF NMR[169]
    Schematic diagram of the detection of SARS-CoV-2 based on colorimetric biosensors[187]
    • Table 1. Comparison of conventional detection methods for SARS-CoV-2

      View table
      View in Article

      Table 1. Comparison of conventional detection methods for SARS-CoV-2

      Object sampleCharacteristicDetection technologyAdvantageDisadvantage
      RNA1. Target: the gene sequences of SARS-CoV-22. Great producibility3. Long detection period4. Possibility of being contaminated and false positive resultWhole genome sequencing1. High accuracy and sensitivity2. Reflecting genetic information of pathogen comprehensively1. Expensive special instruments2. Relying on professionals3. Difficulty in detection on a large scale
      RT-qPCR1. High sensitivity and specificity2. Low cost1. Long amplification time2. High requirements of equipment3. Complex operation
      LAMP1. Isothermal reaction2. High efficiency and speed3. High sensitivity and visualization1. Complex design of primer2. Low specificity
      Microfluidic chip1. Multiple detection of pathogens2. Integration of sample preparation and detection3. Ability in automate analysisDifficulty in chip design, material selection, processing, packaging, and storage
      ddPCR1. High sensitivity and lowest limitation of detection2. Facilitation and high degree of automation3. Quantitative detection1. Small reaction volume 2. Expensive equipment and reagents
      CRISPR1. High speed and low cost2. High sensitivity3. Strong system stability4. On-site detectionThe accuracy of detection needs to be verified
      Antibodies1. Target: human antibodies stimulated by SARS-CoV-22. Easy sample collection and low detection threshold3. Simple operation and high throughput4. Limitation of timeframe5. Lower sensitivity and specificity than those of nucleic acid detectionELISA1. Low difficulty of standardization of carrier2. High sensitivity and specificity3. Simple equipment1. Long detection time and cumbersome steps2. Limited single detection throughout
      LFIA (Colloidal gold method)1. On-site detection caused by easy operation2. High sensitivity and speed3. Low cost4. Mass production1. Only qualitative analysis2. Different reproducibility of different batches of products
      CLIA1. High sensitivity and specificity2. High throughput detection and high degree of automation1. Special instrument2. High detection cost
      Antigen1. Target: SARS-CoV-2 antigen2. Simple and fast operationLFIA (Colloidal gold method)1. Fast and facile operation2. Visualization3. On-site detection and large-scale population screeningLow sensitivity
    • Table 2. Comparison of novel biosensors for SARS-CoV-2 detection

      View table
      View in Article

      Table 2. Comparison of novel biosensors for SARS-CoV-2 detection

      Detection technologyDetection methodObjectSampleRelated materialDetection timeLower detection limitRef.
      SERS-based biosensorsLabelled-SERSS proteinLysis solutionMacro/nanostructure Au substrate15 min10 PFU/mL[73]
      Label-free SERSVirus particlesNasal/throat solutionMacro/nanostructure Au substrate, Au nanoparticles15 min60 copies/mL[72]
      SPR-based biosensorsCombining SPR and LSPRPseudovirus particlesN/AMacro/nanostructure Au substrate, Au nanoparticles15 min370 vp/mL[89]
      Fluorescence biosensors“signal on” modeRNALysis solutionN/A15 samples/45 min600 copies/mL[102]
      Electrochemical biosensorsVoltammetric/amperometric biosensorsRNANasal/throat solutionAu nanoparticles5 min6900 copies/mL[128]
      Impedimetric biosensorsAntibodiesSerumAu nanoparticles30 minN/A[135]
      Potentiometric biosensorsCholinesteraseBloodGraphene and copper~7 s (only detection time)7.9 × 10-8 mol/L[139]
      FET-based biosensorsRNANasal/throat solutionGraphene1 min (only detection time)10-20 copies/mL[150]
      Magnetic biosensorsMagnetoresistanceAntibodiesBloodMagnetic nanoparticles10 min5-10 ng/mL[162]
      Magnetic particle spectroscopy platformsS protein and N proteinPBSMagnetic nanoparticlesN/A1.56 nmol/L[165]
      Nuclear magnetic resonanceAntibodiesBloodMagnetic graphene quantum dot2 min248 vp/mL[169]
      Colorimetric biosensorsAgglomeration of nanoparticlesRNAN/AAu nanoparticles>45 min160 fmol/L[185]
    Tools

    Get Citation

    Copy Citation Text

    Yanyan LI, Yusi PENG, Chenglong LIN, Xiaoying LUO, Zheng TENG, Xi ZHANG, Zhengren HUANG, Yong YANG. Nanomaterials and Biosensing Technology for the SARS-CoV-2 Detection[J]. Journal of Inorganic Materials, 2023, 38(1): 3

    Download Citation

    EndNote(RIS)BibTexPlain Text
    Save article for my favorites
    Paper Information

    Category:

    Received: Apr. 12, 2022

    Accepted: --

    Published Online: Sep. 25, 2023

    The Author Email: TENG Zheng (tengzheng@scdc.sh.cn), YANG Yong (yangyong@mail.sic.ac.cn)

    DOI:10.15541/jim20220218

    Topics